Establishment of Paclitaxel-resistance Cervical Carcinoma Cell Line Hela/PTX and Study on its Biological Characteristics
- VernacularTitle:人宫颈癌紫杉醇耐药细胞株Hela/PTX的建立及其生物特性研究
- Author:
Qian LI
1
;
Xuan WANG
;
Dongfeng YIN
Author Information
1. 新疆军区总医院药剂科 乌鲁木齐830000
- Keywords:
Paclitaxel;
Human cervical cancer;
Multidrug resistant;
Hela cell line
- From:
China Pharmacist
2018;21(5):787-791
- CountryChina
- Language:Chinese
-
Abstract:
Objective:To establish a paclitaxel (PTX)-resistance cell line of human cervical carcinoma Hela/PTX and investigate its biological features. Methods:Using Hela as the negative cells,drug-resistant cervical cancer Hela/PTX cells were applied as the target cells. The morphology changes were observed under an optical microscope;the drug resistance of Hela/PTX to different chemotherapeutic drugs was detected by CCK-8 method. The accumulation of drugs in the cells was determined by HPLC. The expression of P-glycoprotein (P-gp), Survivin protein and mRNA was detected by Western blot and RT-PCR. Results:Hela/PTX multidrug resistant cell line was successfully established. The resistance index to PTX was 58.40 and the resistance index of cross-resistance to docetaxel and 5-fluorouracil was 8.11 and 4.62,respectively. The mRNA expression level of P-gp and Survivin protein in Hela/PTX cells respectively was(9.93 +0.90) times(P < 0.05) and(3.02 +0.57) times(P <0.05) of that in Hela cells. The expression of P-gp and Survivin protein in drug-resistant cells was significantly higher than that in parental cells.Conclusion:Human cervical cancer resistant cell line Hela/PTX with the basic biological characteristics of multidrug resistance is successfully established, which can be used as an in vitro model for the studies on paclitaxel resistance mechanism and provide experimental basis for the studies of multidrug resistance mechanism of cervical cancer.
